BBI

Brickell Biotech (BBI)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BBI
DataOraFonteTitoloSimboloCompagnia
10/05/202322:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BBIBrickell Biotech Inc
01/05/202322:44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:BBIBrickell Biotech Inc
22/02/202322:04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BBIBrickell Biotech Inc
13/02/202323:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BBIBrickell Biotech Inc
27/01/202300:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BBIBrickell Biotech Inc
14/11/202212:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BBIBrickell Biotech Inc
12/09/202212:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BBIBrickell Biotech Inc
06/09/202222:44Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:BBIBrickell Biotech Inc
02/09/202222:08Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BBIBrickell Biotech Inc
23/06/202222:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BBIBrickell Biotech Inc
22/06/202212:03Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BBIBrickell Biotech Inc
17/06/202215:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BBIBrickell Biotech Inc
07/06/202222:29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:BBIBrickell Biotech Inc
27/05/202214:59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BBIBrickell Biotech Inc
24/05/202223:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BBIBrickell Biotech Inc
15/03/202212:48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BBIBrickell Biotech Inc
28/10/202123:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BBIBrickell Biotech Inc
03/09/202114:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BBIBrickell Biotech Inc
22/07/202115:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BBIBrickell Biotech Inc
19/07/202123:27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:BBIBrickell Biotech Inc
15/03/202113:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BBIBrickell Biotech Inc
09/03/202122:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BBIBrickell Biotech Inc
22/10/202012:11Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BBIBrickell Biotech Inc
24/09/202021:47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BBIBrickell Biotech Inc
13/08/202023:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BBIBrickell Biotech Inc
03/08/202022:05GlobeNewswire Inc.Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020NASDAQ:BBIBrickell Biotech Inc
18/06/202004:00GlobeNewswire Inc.Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public OfferingNASDAQ:BBIBrickell Biotech Inc
15/06/202012:30GlobeNewswire Inc.Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Pa...NASDAQ:BBIBrickell Biotech Inc
13/05/202022:01GlobeNewswire Inc.Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:BBIBrickell Biotech Inc
04/05/202022:05GlobeNewswire Inc.Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020NASDAQ:BBIBrickell Biotech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BBI
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network